Activated EGFR stimulates MUC1 expression in human uterine and pancreatic cancer cell lines

Journal of Cellular Biochemistry

Volumn 114, Issue 10, 2013, Pages 2314-2322

  Dharmaraj, Neeraja ^a   Engel, Brian J ^a   Carson, Daniel D ^a,b  

^a RICE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

EGF; EGFR; MUC1; ROSIGLITAZONE

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; MUCIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROGESTERONE; PROGESTERONE RECEPTOR; ROSIGLITAZONE;

ARTICLE; CANCER CELL; CELL LEVEL; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; STRESS;

EID: 84882306631     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24580     Document Type: Article

References (65)

1. Akinyeke TO, Stewart LV,. 2011. Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARgamma-independent mechanism. Cancer Biol Ther 11: 1046-1058.
2. Alwan HA, van Zoelen EJ, van Leeuwen JE,. 2003. Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination. J Biol Chem 278: 35781-35790.
3. Beguinot L, Lyall RM, Willingham MC, Pastan I,. 1984. Down-regulation of the epidermal growth factor receptor in KB cells is due to receptor internalization and subsequent degradation in lysosomes. Proc Natl Acad Sci USA 81: 2384-2388.
4. Behrens ME, Grandgenett PM, Bailey JM, Singh PK, Yi CH, Yu F, Hollingsworth MA,. 2010. The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF. Oncogene 29: 5667-5677.
5. Birdsall MA, Hopkisson JF, Grant KE, Barlow DH, Mardon HJ,. 1996. Expression of heparin-binding epidermal growth factor messenger RNA in the human endometrium. Mol Hum Reprod 2: 31-34.
6. Bitler BG, Goverdhan A, Schroeder JA,. 2010. MUC1 regulates nuclear localization and function of the epidermal growth factor receptor. J Cell Sci 123: 1716-1723.
7. Brayman M, Thathiah A, Carson DD,. 2004. MUC1: A multifunctional cell surface component of reproductive tissue epithelia. Reprod Biol Endocrinol 2: 4.
8. Carpenter G, Cohen S,. 1976. 125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts. J Cell Biol 71: 159-171.
9. Carson DD,. 2008. The cytoplasmic tail of MUC1: A very busy place. Sci Signal 1: pe35.
10. Carson DD, Bagchi I, Dey SK, Enders AC, Fazleabas AT, Lessey BA, Yoshinaga K,. 2000. Embryo implantation. Dev Biol 223: 217-237.
11. Carson DD, Dharmaraj N, Wang P,. 2008. Transcriptional control of the expression of MUC1. Exp Rev Endocrinol Metabol 3: 463-471.
12. d'Abramo C, Massone S, Zingg JM, Pizzuti A, Marambaud P, Dalla Piccola B, Azzi A, Marinari UM, Pronzato MA, Ricciarelli R,. 2005. Role of peroxisome proliferator-activated receptor gamma in amyloid precursor protein processing and amyloid beta-mediated cell death. Biochem J 391: 693-698.
13. Das SK, Wang XN, Paria BC, Damm D, Abraham JA, Klagsbrun M, Andrews GK, Dey SK,. 1994. Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: A possible ligand for interaction with blastocyst EGF-receptor in implantation. Development 120: 1071-1083.
14. Dharmaraj N, Wang P, Carson DD,. 2010. Cytokine and progesterone receptor interplay in the regulation of MUC1 gene expression. Mol Endocrinol 24: 2253-2266.
15. Di Cristofano A, Ellenson LH,. 2007. Endometrial carcinoma. Annu Rev Pathol 2: 57-85.
16. Galli A, Ceni E, Crabb DW, Mello T, Salzano R, Grappone C, Milani S, Surrenti E, Surrenti C, Casini A,. 2004. Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms. Gut 53: 1688-1697.
17. Gendler SJ,. 2001. MUC1, the renaissance molecule. J Mammary Gland Biol Neoplasia 6: 339-353.
18. Gendler SJ, Spicer AP,. 1995. Epithelial mucin genes. Annu Rev Physiol 57: 607-634.
19. Grunwald V, Hidalgo M,. 2003. Development of the epidermal growth factor receptor inhibitor Tarceva (OSI-774). Adv Exp Med Biol 532: 235-246.
20. Hofmann GE, Scott RT, Jr., Bergh PA, Deligdisch L,. 1991. Immunohistochemical localization of epidermal growth factor in human endometrium, decidua, and placenta. J Clin Endocrinol Metab 73: 882-887.
21. Hollingsworth MA, Swanson BJ,. 2004. Mucins in cancer: Protection and control of the cell surface. Nat Rev Cancer 4: 45-60.
22. Jin C, Rajabi H, Rodrigo CM, Porco JA, Jr., Kufe D,. 2012. Targeting the eIF4A RNA helicase blocks translation of the MUC1-C oncoprotein. Oncogene 32 (17): 2179-2188.
23. Julian J, Dharmaraj N, Carson DD,. 2009. MUC1 is a substrate for gamma-secretase. J Cell Biochem 108: 802-815.
24. Katzmann DJ, Odorizzi G, Emr SD,. 2002. Receptor downregulation and multivesicular-body sorting. Nat Rev Mol Cell Biol 3: 893-905.
25. Kovarik A, Peat N, Wilson D, Gendler SJ, Taylor-Papadimitriou J,. 1993. Analysis of the tissue-specific promoter of the MUC1 gene. J Biol Chem 268: 9917-9926.
26. Kufe DW,. 2008. Targeting the human MUC1 oncoprotein: A tale of two proteins. Cancer Biol Ther 7: 81-84.
27. Laemmli UK,. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
28. Lagow EL, Carson DD,. 2002. Synergistic stimulation of MUC1 expression in normal breast epithelia and breast cancer cells by interferon-gamma and tumor necrosis factor-alpha. J Cell Biochem 86: 759-772.
29. Lau SK, Shields DJ, Murphy EA, Desgrosellier JS, Anand S, Huang M, Kato S, Lim ST, Weis SM, Stupack DG, Schlaepfer DD, Cheresh DA,. 2012. EGFR-mediated carcinoma cell metastasis mediated by integrin alphavbeta5 depends on activation of c-Src and cleavage of MUC1. PLoS ONE 7: e36753.
30. Lessey BA, Gui Y, Apparao KB, Young SL, Mulholland J,. 2002. Regulated expression of heparin-binding EGF-like growth factor (HB-EGF) in the human endometrium: A potential paracrine role during implantation. Mol Reprod Dev 62: 446-455.
31. Levitzki A, Gazit A,. 1995. Tyrosine kinase inhibition: An approach to drug development. Science 267: 1782-1788.
32. Li Y, Ren J, Yu W, Li Q, Kuwahara H, Yin L, Carraway KL, III, Kufe D,. 2001. The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin. J Biol Chem 276: 35239-35242.
33. Li X, Wang L, Nunes DP, Troxler RF, Offner GD,. 2005. Suppression of MUC1 synthesis downregulates expression of the epidermal growth factor receptor. Cancer Biol Ther 4: 968-973.
34. Luttges J, Feyerabend B, Buchelt T, Pacena M, Kloppel G,. 2002. The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas. Am J Surg Pathol 26: 466-471.
35. McAuley JL, Linden SK, Png CW, King RM, Pennington HL, Gendler SJ, Florin TH, Hill GR, Korolik V, McGuckin MA,. 2007. MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest 117: 2313-2324.
36. Merlin J, Stechly L, de Beauce S, Monte D, Leteurtre E, van Seuningen I, Huet G, Pigny P,. 2011. Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells. Oncogene 30: 2514-2525.
37. Mitsudomi T, Yatabe Y,. 2010. Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer. FEBS J 277: 301-308.
38. Pantano F, Baldi A, Santini D, Vincenzi B, Borzomati D, Vecchio FM, Castri F, Antinori A, Caraglia M, Magistrelli P, Coppola R, Tonini G,. 2009. MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients. Cancer Biol Ther 8: 996-999.
39. Parry S, Hanisch FG, Leir SH, Sutton-Smith M, Morris HR, Dell A, Harris A,. 2006. N-Glycosylation of the MUC1 mucin in epithelial cells and secretions. Glycobiology 16: 623-634.
40. Pochampalli MR, el Bejjani RM, Schroeder JA,. 2007. MUC1 is a novel regulator of ErbB1 receptor trafficking. Oncogene 26: 1693-1701.
41. Porzio MA, Pearson AM,. 1977. Improved resolution of myofibrillar proteins with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochim Biophys Acta 490: 27-34.
42. Qin C, Burghardt R, Smith R, Wormke M, Stewart J, Safe S,. 2003. Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells. Cancer Res 63: 958-964.
43. Ramasamy S, Duraisamy S, Barbashov S, Kawano T, Kharbanda S, Kufe D,. 2007. The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop. Mol Cell 27: 992-1004.
44. Rangwala SM, Lazar MA,. 2004. Peroxisome proliferator-activated receptor gamma in diabetes and metabolism. Trends Pharmacol Sci 25: 331-336.
45. Ren J, Agata N, Chen D, Li Y, Yu WH, Huang L, Raina D, Chen W, Kharbanda S, Kufe D,. 2004. Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents. Cancer Cell 5: 163-175.
46. Schneider MR, Wolf E,. 2008. The epidermal growth factor receptor and its ligands in female reproduction: Insights from rodent models. Cytokine Growth Factor Rev 19: 173-181.
47. Schneider MR, Wolf E,. 2009. The epidermal growth factor receptor ligands at a glance. J Cell Physiol 218: 460-466.
48. Schroeder JA, Thompson MC, Gardner MM, Gendler SJ,. 2001. Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland. J Biol Chem 276: 13057-13064.
49. Shalom-Barak T, Nicholas JM, Wang Y, Zhang X, Ong ES, Young TH, Gendler SJ, Evans RM, Barak Y,. 2004. Peroxisome proliferator-activated receptor gamma controls Muc1 transcription in trophoblasts. Mol Cell Biol 24: 10661-10669.
50. Shtiegman K, Yarden Y,. 2003. The role of ubiquitylation in signaling by growth factors: Implications to cancer. Semin Cancer Biol 13: 29-40.
51. Singh M, Chaudhry P, Asselin E,. 2011. Bridging endometrial receptivity and implantation: Network of hormones, cytokines, and growth factors. J Endocrinol 210: 5-14.
52. Sorkin A, Goh LK,. 2008. Endocytosis and intracellular trafficking of ErbBs. Exp Cell Res 314: 3093-3106.
53. Sorkin A, Von Zastrow M,. 2002. Signal transduction and endocytosis: Close encounters of many kinds. Nat Rev Mol Cell Biol 3: 600-614.
54. Stoorvogel W, Kerstens S, Fritzsche I, den Hartigh JC, Oud R, van der Heyden MA, Voortman J, van Bergen en Henegouwen PM,. 2004. Sorting of ligand-activated epidermal growth factor receptor to lysosomes requires its actin-binding domain. J Biol Chem 279: 11562-11569.
55. Stoscheck CM, Carpenter G,. 1984a. Characterization of the metabolic turnover of epidermal growth factor receptor protein in A-431 cells. J Cell Physiol 120: 296-302.
56. Stoscheck CM, Carpenter G,. 1984b. Down regulation of epidermal growth factor receptors: Direct demonstration of receptor degradation in human fibroblasts. J Cell Biol 98: 1048-1053.
57. Sun X, Ritzenthaler JD, Zheng Y, Roman J, Han S,. 2009. Rosiglitazone inhibits alpha4 nicotinic acetylcholine receptor expression in human lung carcinoma cells through peroxisome proliferator-activated receptor gamma-independent signals. Mol Cancer Ther 8: 110-118.
58. Thien CB, Walker F, Langdon WY,. 2001. RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation. Mol Cell 7: 355-365.
59. Torres MP, Chakraborty S, Souchek J, Batra SK,. 2012. Mucin-based targeted pancreatic cancer therapy. Curr Pharm Des 18: 2472-2481.
60. Vitale G, Zappavigna S, Marra M, Dicitore A, Meschini S, Condello M, Arancia G, Castiglioni S, Maroni P, Bendinelli P, Piccoletti R, van Koetsveld PM, Cavagnini F, Budillon A, Abbruzzese A, Hofland LJ, Caraglia M,. 2012. The PPAR-gamma agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-beta treated pancreatic cancer cells. Biotechnol Adv 30: 169-184.
61. Wang P, Dharmaraj N, Brayman MJ, Carson DD,. 2010. Peroxisome proliferator-activated receptor gamma activation inhibits progesterone- stimulated human MUC1 expression. Mol Endocrinol 24: 1368-1379.
62. Weber SM, Chambers KT, Bensch KG, Scarim AL, Corbett JA,. 2004. PPARgamma ligands induce ER stress in pancreatic beta-cells: ER stress activation results in attenuation of cytokine signaling. Am J Physiol Endocrinol Metab 287: E1171-E1177.
63. Yarden Y,. 2001. The EGFR family and its ligands in human cancer. Signalling mechanisms and therapeutic opportunities. Eur J Cancer 37 (Suppl 4): S3-S8.
64. Yonezawa S, Goto M, Yamada N, Higashi M, Nomoto M,. 2008. Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior. Proteomics 8: 3329-3341.
65. Yoo HJ, Barlow DH, Mardon HJ,. 1997. Temporal and spatial regulation of expression of heparin-binding epidermal growth factor-like growth factor in the human endometrium: A possible role in blastocyst implantation. Dev Genet 21: 102-108.